{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"page_content": "Structural Biology 14, 264\u2013272 (2004).\n\n15. Alsafadi, S. et al. Cancer-associated SF3B1 mutations affect alternative splicing by\n\npromoting alternative branchpoint usage. Nat Commun 7, (2016).\n\n16.\n\nLiberante, F. G. et al. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-\n\nmutant myelodysplastic syndromes as a therapeutic vulnerability. Scientific Reports 9,\n\n(2019).\n\n17.\n\nLiu, Z. et al. Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic\n\nvector. Scientific Reports 2017 7:1 7, 1\u20139 (2017).\n\n18. Kahles, A. et al. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705\n\nPatients. Cancer Cell 34, 211-224.e6 (2018).\n\n19. Grosso, A. R. et al. Tissue-specific splicing factor gene expression signatures. Nucleic Acids\n\nResearch 36, 4823 (2008).\n\n64\n\n20.\n\nFernandes, M. T. et al. Lymphotoxin-\u03b2 receptor in microenvironmental cells promotes the\n\ndevelopment of T-cell acute lymphoblastic leukaemia with cortical/mature\n\nimmunophenotype. Br J Haematol 171, 736\u2013751 (2015).\n\n21. Ha, S. Y., Song, D. H., Hwang, S. H., Cho, S. Y. & Park, C. K. Expression of prothymosin \u03b1\n\npredicts early recurrence and poor prognosis of hepatocellular carcinoma. Hepatobiliary\n\nand Pancreatic Diseases International 14, 171\u2013177 (2015).\n\n22.\n\nZhang, M. et al. Increased expression of Prothymosin-\u03b1, independently or combined with\n\nTP53, correlates with poor prognosis in colorectal cancer. International Journal of Clinical\n\nand Experimental Pathology 7, 4867 (2014).\n\n23. Tsai, Y. S. et al. Aberrant Prothymosin-alpha Expression in Human Bladder Cancer. Urology\n\n73, 188\u2013192 (2009).\n\n24.\n\nJung, J. et al. Translationally controlled tumor protein induces human breast epithelial cell\n\ntransformation through the activation of Src. Oncogene 30, 2264\u20132274 (2011).\n\n25. Arcuri, F. et al. Translationally controlled tumor protein (TCTP) in the human prostate and\n\nprostate cancer cells: Expression, distribution, and calcium binding activity. Prostate 60,", "metadata": {"source": "./documents/UC Irvine/JW_Dissertation_20220824.pdf"}, "type": "Document"}}